The global solitary fibrous tumor (SFT) treatment market is witnessing steady growth as awareness of rare cancers, improvements in diagnostic techniques, and advancements in treatment approaches create new opportunities for healthcare providers and pharmaceutical companies. According to market estimates, the market was valued at US$ 36.5 million in 2020 and is projected to reach US$ 59.3...